In recent years, the life sciences and pharma industries have experienced an increase in regulatory oversight while also facing pressure to respond to global...
Avirmax Inc., a company focused on delivering protein therapeutics via recombinant adeno-associated viral (rAAV) vectors announced that the United States Patent and Trademark Office...
Ascletis Pharma Inc. announces dosing of 24 healthy subjects of the first 3 cohorts in multiple-dose escalation Phase I clinical trial of oral RNA-dependent...
Mission Bio, the pioneer in single-cell DNA and multi-omics analysis, announced the availability of the Tapestri VCN Assay, the first high-throughput commercial single-cell assay...
